A trio of ASCRS presentations collectively offer insight to surgeons, suggesting that glaucoma drops harm meibomian glands, ...
When preparing for cataract surgery in patients with retinal pathologies, ophthalmologists must be sure to set reasonable ...
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the presentation of new scientific data and ...
Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for ...
Ab-interno canaloplasty significantly reduces IOP and medication burden in glaucoma patients over 20.5 months, with a high safety profile.
American hospitals see mountains of surgical waste as the cost of infection control. Indian hospitals show that’s not so.
View Bausch + Lomb Corporation BLCO stock quote prices, financial information, real-time forecasts, and company news from CNN.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results